ORIC Pharmaceuticals, Inc.
CD73 inhibitors
Last updated:
Abstract:
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Status:
Grant
Type:
Utility
Filling date:
9 May 2018
Issue date:
28 Sep 2021